[Federal Register Volume 89, Number 25 (Tuesday, February 6, 2024)]
[Notices]
[Page 8246]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-02255]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division


Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--Medical Technology Enterprise Consortium

    Notice is hereby given that, on January 9, 2024, pursuant to 
section 6(a) of the National Cooperative Research and Production Act of 
1993, 15 U.S.C. 4301 et seq. (``the Act''), Medical Technology 
Enterprise Consortium (``MTEC'') has filed written notifications 
simultaneously with the Attorney General and the Federal Trade 
Commission disclosing changes in its membership. The notifications were 
filed for the purpose of extending the Act's provisions limiting the 
recovery of antitrust plaintiffs to actual damages under specified 
circumstances. Specifically, Act Medical, Ltd., Loughborough, GREAT 
BRITIAN; Affinity Associates LLC, Holden Beach, NC; Akthelia, 
Reykjavik, ICELAND; Altra, Inc., Las Vegas, NV; Amazon Web Services, 
Arlington, VA; AutoMedicus Corp., Pasadena, CA; AutonomUS Medical 
Technologies, Inc., Cambridge, MA; Collabralink Technologies, Inc., dba 
Groundswell, McLean, VA; Compression Works, Inc., Birmingham, AL; 
Convergent Clinical, Inc., Carlsbad, CA; DesiCorp, Inc., Louisville, 
KY; Digital Velocity Partners LLC, Chevy Chase, MD; Duquesne University 
of the Holy Spirit, Pittsburgh, PA; E4 Technology, Inc., Huntsville, 
AL; Elemance LLC, Winston Salem, NC; Endpoint Health, Palo Alto, CA; 
Epineuron Technologies, Inc., Mississauga, CANADA; First Nation Group 
LLC, Niceville, FL; Fistula Solution Corp., Scandia, MN; Global 
Resonance Technologies LLC, Shelburne, VT; Grande Delta Corp., Alameda, 
CA; GrayMatters Health Ltd., Haifa, ISRAEL; Halomine, Inc., Ithaca, NY; 
International Scientific Advisors, Inc. dba MilMed Connect, Beaverton, 
OR; JDSAT, Inc., Mclean, VA; JLM ExoGrade LLC, Austin, TX; 
KardioGenics, Inc., San Jose, CA; Legacy US, Inc., Boise, ID; Longhorn 
Vaccines and Diagnostics LLC, Bethesda, MD; Longhorn Vaccines and 
Diagnostics LLC, Bethesda, MD; MedStar Health Research Institute, Inc., 
Hyattsville, MD; Muscle Activation Techniques, Englewood, CO; Nuream, 
Inc., Wilmington, NC; NZ Technologies, Inc., Vancouver, CANADA; Padagis 
US LLC, Allegan, MI; Physcient Surgical, Inc., Durham, NC; Powerboard 
Life Systems, Inc., San Francisco, CA; ppx-TEC LLC, Jackson, MS; RedC 
Biotech, Ltd., Bnei Zion, ISRAEL; RESDEF, Inc., Chicago, IL; Sigma 
Genetics, Inc. Seattle, WA; Soar Technology LLC, Ann Arbor, MI; Sperry 
Bio, Inc., Springfield, VT; Sterogene Bioseparations, Inc., Carlsbad, 
CA; Sutton's Creek, Westlake, CA; Syracuse University, Syracuse, NY; 
Tachmed, Inc., New York, NY; Texas Christian University, Fort Worth, 
TX; The Huntsman Mental Health Foundation, Salt Lake City, UT; Turner 
Imaging Systems, Orem, UT; University of Alabama, Huntsville, 
Huntsville, AL; University of Chicago, Chicago, IL; University of Texas 
Southwestern Medical Center, Dallas, TX; Vascarta Inc., Short Hills, 
NJ; Vaxart, Inc., South San Francisco, CA; Vaxxas, Cambridge, MA; 
Verndari, Inc., Rancho, Cordova, CA; Vigor Medical Technologies, Ltd., 
Haifa, ISRAEL; Virpax Pharmaceuticals, Inc., Berwyn, PA; Vivosang, 
Inc., Santa Fe, NM; and Xtory, Inc., Arlington, MA, have been added as 
parties to this venture.
    No other changes have been made in either the membership or planned 
activity of the group research project. Membership in this group 
research project remains open, and MTEC intends to file additional 
written notifications disclosing all changes in membership.
    On May 9, 2014, MTEC filed its original notification pursuant to 
section 6(a) of the Act. The Department of Justice published a notice 
in the Federal Register pursuant to section 6(b) of the Act on June 9, 
2014 (79 FR 32999).
    The last notification was filed with the Department on October 2, 
2023. A notice was published in the Federal Register pursuant to 
section 6(b) of the Act on December 15, 2023 (88 FR 86932).

Suzanne Morris,
Deputy Director Civil Enforcement Operations, Antitrust Division.
[FR Doc. 2024-02255 Filed 2-5-24; 8:45 am]
BILLING CODE